We develop targeted and scientifically validated fixed-dose combinations of synthetic cannabinoid and psychedelic agents, applying proprietary insights in an effort to create long term value for our patients and shareholders. We focus on clinical indications that we believe represent unmet or inadequately addressed medical needs and also represent compelling commercial opportunities.We are pursuing FDA registration and marketi...
We develop targeted and scientifically validated fixed-dose combinations of synthetic cannabinoid and psychedelic agents, applying proprietary insights in an effort to create long term value for our patients and shareholders. We focus on clinical indications that we believe represent unmet or inadequately addressed medical needs and also represent compelling commercial opportunities.We are pursuing FDA registration and marketing approval for each product and therapy under development.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.